Physician

Khosrow Mehrany, M.D.

According to 2025 Medicare claims, Khosrow Mehrany, M.D. (NPI: 1235123142) practices micrographic dermatologic surgery in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is KHOSROW MEHRANY M D INC (NPI: 1073721593; TIN: 208850431) and primary practice location at 95126-2904.

Mehrany's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,001 traditional Medicare patients, billed 23,145 HCPCS/CPT codes, and received $16,857,999 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 913 prescription claims across 621 beneficiaries totaling $11,411 in drug costs, led by Minocycline Hcl (Minocycline Hcl). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,121,060 to $16,857,999. In contrast, Part D prescription costs have declined steadily, from $18,998 to $11,411. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$8.4M$17M2015 Medicare payment: $1,121,060 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,288,450 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,555,399 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,184,620 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $555,822 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $650,966 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,610,737 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,423,620 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $9,011,148 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $16,857,999 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159379,087$1,121,060
20161,04710,257$1,288,450
20171,08411,002$1,555,399
201896211,876$1,184,620
20197996,195$555,822
20207757,512$650,966
202198816,649$1,610,737
20221,12617,916$2,423,620
20231,13424,947$9,011,148
20241,00123,145$16,857,999

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$21K2015 Drug cost: $18,998 (USD; Tot_Drug_Cst)2016 Drug cost: $19,877 (USD; Tot_Drug_Cst)2017 Drug cost: $21,089 (USD; Tot_Drug_Cst)2018 Drug cost: $17,463 (USD; Tot_Drug_Cst)2019 Drug cost: $14,625 (USD; Tot_Drug_Cst)2020 Drug cost: $12,497 (USD; Tot_Drug_Cst)2021 Drug cost: $17,689 (USD; Tot_Drug_Cst)2022 Drug cost: $16,431 (USD; Tot_Drug_Cst)2023 Drug cost: $15,100 (USD; Tot_Drug_Cst)2024 Drug cost: $11,411 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015623883$18,998
2016709982$19,877
20177601,107$21,089
2018527791$17,463
2019420621$14,625
2020372540$12,497
2021577992$17,689
2022608921$16,431
2023607894$15,100
2024621913$11,411

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks298327$431
11102Biopsy of related skin growth, first growth290322$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more684859$73
17000Destruction of precancer skin growth, 1 growth669794$43
17003Destruction of precancer skin growth, 2-14 growths6044,340$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Minocycline HclMinocycline Hcl6666,707$7,337
CephalexinCephalexin82821$1,041
ImiquimodImiquimod14554$362
Triamcinolone AcetonideTriamcinolone Acetonide421,050$297
Ciprofloxacin HclCiprofloxacin Hcl39401$292

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Khosrow Mehrany, M.D.?

Tedicare shows public-source Medicare data for Khosrow Mehrany, M.D. (NPI 1235123142), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Khosrow Mehrany, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Khosrow Mehrany, M.D.?

Khosrow Mehrany, M.D. is linked to KHOSROW MEHRANY M D INC (billing NPI 1073721593) in the available physician profile data.

Does Khosrow Mehrany, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.